In contrast, the post-therapy RD rhabdomyosarcoma cell line exhibited increased levels solely in the mitochondrial fission mediator DRP1, along with strong up-regulation of its activating phosphorylation. This evidence concerns the gene DNM1L and rhabdomyosarcoma.